IJCP Editorial Team
Kawasaki disease (KD) is a systemic vasculitis that primarily affects children under 5 years of age and has emerged as the leading cause of acquired heart disease in children, overtaking acute rheumatic fever.
Epidemiological data from Chandigarh, India, between 1994 and 2019 show a gradual monthly increase in incidence of KD: 0.002 cases per 100,000 children under 5 years and 0.0165 cases per 100,000 children under 15 years.
Additionally, projections for 2020–2030 suggest that this increase will continue, with an expected monthly increase of 0.0177 cases per 100,000 children under 15.
KD creates serious public health concerns because of its cardiovascular complications, such as coronary artery aneurysms, myocardial ischemia, and sudden cardiac death. Low awareness, delayed diagnosis, and expensive treatment add to the clinical and financial burden of the disease.
Early recognition of Kawasaki disease and timely treatment are crucial to prevent long-term health problems. Predictive models emphasize the urgent need to dedicate resources to manage this growing public health concern.
Reference:
Dixit J, Pilania RK, Nimesh R, Singh S, Prinja S. Public Health Impact of Kawasaki Disease in India: Projections for 2030. Indian Pediatrics. 2025 Jun 17:1-7.
https://www.indianpediatrics.net/sep2025/692.pdf
Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.
Please login to comment on this article